Insider Buying: Knight Therapeutics Inc (TSE:GUD) Director Purchases 20,000 Shares of Stock Trent Times
Knight Therapeutics Inc (TSE:GUD) Director Robert Nathaniel Lande acquired 20000 shares of the business’s stock in a transaction dated Thursday, July 11th.